[HTML][HTML] Commercially available molecular tests for human papillomaviruses: a global overview
Background Molecular tests for detection of human papillomaviruses (HPVs) play a crucial
role in the prevention of cervical cancer, including recently announced elimination efforts …
role in the prevention of cervical cancer, including recently announced elimination efforts …
Human papillomaviruses-associated cancers: an update of current knowledge
Human papillomaviruses (HPVs), which are small, double-stranded, circular DNA viruses
infecting human epithelial cells, are associated with various benign and malignant lesions of …
infecting human epithelial cells, are associated with various benign and malignant lesions of …
Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
Commercial molecular tests for human papillomaviruses (HPV) are invaluable diagnostic
tools in cervical carcinoma screening and management of women with cervical …
tools in cervical carcinoma screening and management of women with cervical …
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
VV Sahasrabuddhe, P Luhn, N Wentzensen - Future microbiology, 2011 - Taylor & Francis
While organized screening programs in industrialized countries have significantly reduced
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …
cervical cancer incidence, cytology-based screening has several limitations. Equivocal or …
HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
Background Genital infection with certain types of Human papillomavirus (HPV) is a major
cause of cervical cancer globally. For early detection of premalignant dysplasia, evidences …
cause of cervical cancer globally. For early detection of premalignant dysplasia, evidences …
Histology of cervical intraepithelial neoplasia and the role of biomarkers
CM Martin, JJ O'Leary - Best practice & research Clinical obstetrics & …, 2011 - Elsevier
Accurate histological grading of cervical intraepithelial neoplasia (CIN) lesions is important
for clinical management of patients, because CIN1 and CIN2 and 3 lesions are treated …
for clinical management of patients, because CIN1 and CIN2 and 3 lesions are treated …
[HTML][HTML] Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage-and brush-based self-samples to detect cervical (pre) cancer in HPV-positive …
LMA De Strooper, VMJ Verhoef, J Berkhof… - Gynecologic …, 2016 - Elsevier
Objectives DNA methylation analysis of cancer-related genes is a promising tool for HPV-
positive women to identify those with cervical (pre) cancer (CIN3+) in need of treatment …
positive women to identify those with cervical (pre) cancer (CIN3+) in need of treatment …
Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
LMA De Strooper, J Berkhof… - … journal of cancer, 2018 - Wiley Online Library
DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has
shown a good clinical performance in detecting cervical cancer and advanced CIN lesions …
shown a good clinical performance in detecting cervical cancer and advanced CIN lesions …
Nucleic acid tests for the detection of alpha human papillomaviruses
Testing for high-risk types of alpha human papillomaviruses (HPV) is an invaluable part of
clinical guidelines for cervical carcinoma screening, management and treatment. In this …
clinical guidelines for cervical carcinoma screening, management and treatment. In this …
[HTML][HTML] A review of the clinical performance of the Aptima HPV assay
J Haedicke, T Iftner - Journal of Clinical Virology, 2016 - Elsevier
This comprehensive review compiles published data from 62 original articles comparing
different HPV tests and one meta-analysis on the clinical performance of the Aptima HR HPV …
different HPV tests and one meta-analysis on the clinical performance of the Aptima HR HPV …